R
Risa M Hoffman
Researcher at University of California, Los Angeles
Publications - 119
Citations - 1735
Risa M Hoffman is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 19, co-authored 98 publications receiving 1182 citations. Previous affiliations of Risa M Hoffman include University of California & Eduardo Mondlane University.
Papers
More filters
Journal ArticleDOI
Effects of Highly Active Antiretroviral Therapy Duration and Regimen on Risk for Mother-to-Child Transmission of HIV in Johannesburg, South Africa
Risa M Hoffman,Vivian Black,Karl Technau,Karin van der Merwe,Judith S. Currier,Ashraf Coovadia,Matthew Chersich +6 more
TL;DR: Late initiation of HAART is associated with increased risk of mother-to-child transmission of HIV among women in Africa who start treatment for advanced immunosuppression, and strategies are needed to facilitate earlier identification of HIV-infected women.
Journal ArticleDOI
Birth outcomes in South African women receiving highly active antiretroviral therapy: a retrospective observational study
Karin van der Merwe,Risa M Hoffman,Vivian Black,Matthew Chersich,Matthew Chersich,Ashraf Coovadia,Helen Rees +6 more
TL;DR: In this immunocompromised cohort, in utero HAART exposure was not associated with low birth weight and preterm birth, highlighting the importance of earlier HAART initiation in women to optimize maternal health and improve infant outcomes.
Journal ArticleDOI
Hydroxychloroquine as Postexposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 Infection : A Randomized Trial.
Ruanne V. Barnabas,Elizabeth R. Brown,Anna Bershteyn,Helen C. Stankiewicz Karita,Christine Johnston,Lorna E. Thorpe,Angelica Kottkamp,Kathleen M. Neuzil,Miriam K. Laufer,Meagan E. Deming,Michael K. Paasche-Orlow,Patricia Kissinger,Alfred Luk,Kristopher M Paolino,Raphael J. Landovitz,Risa M Hoffman,Torin T Schaafsma,Meighan Krows,Katherine K. Thomas,Susan Morrison,Harald S. Haugen,Lara Kidoguchi,Mark H. Wener,Alexander L. Greninger,Meei Li Huang,Keith R. Jerome,Anna Wald,Connie Celum,Helen Y. Chu,Jared M. Baeten +29 more
TL;DR: This randomized controlled trial tests hydroxychloroquine as postexposure prophylaxis for SARS-CoV-2 infection.
Journal ArticleDOI
Effect of facility-based HIV self-testing on uptake of testing among outpatients in Malawi: a cluster-randomised trial.
Kathryn Dovel,Frackson Shaba,O Agatha Offorjebe,O Agatha Offorjebe,Kelvin Balakasi,Mike Nyirenda,Khumbo Phiri,Sundeep Gupta,Vincent Wong,Chi-Hong Tseng,Brooke E Nichols,Brooke E Nichols,Refiloe Cele,Eric Lungu,Tobias Masina,Thomas J. Coates,Risa M Hoffman +16 more
TL;DR: Filtration-based HIV self-testing increased HIV testing among outpatients in Malawi, with a minimal risk of adverse events, and should be considered for scale-up in settings with a high unmet need for HIV testing.
Journal ArticleDOI
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial
Shahin Lockman,Shahin Lockman,Sean S Brummel,Lauren Ziemba,Lynda Stranix-Chibanda,Katie McCarthy,Anne Coletti,Patrick Jean-Philippe,Ben Johnston,Chelsea Krotje,Lee Fairlie,Risa M Hoffman,Paul E. Sax,Sikhulile Moyo,Nahida Chakhtoura,Jeffrey S. A. Stringer,Gaerolwe Masheto,Violet Korutaro,Haseena Cassim,Blandina T. Mmbaga,Esau Joao,Sherika Hanley,Lynette Purdue,Lewis B. Holmes,Jeremiah D. Momper,Roger L. Shapiro,Navdeep K Thoofer,James F. Rooney,Lisa M. Frenkel,K. Rivet Amico,Lameck Chinula,Judith S. Currier,Brookie M. Best,Cheryl Blanchette,Renee Browning,Yao Cheng,Andee Fox,Nagawa Jaliaah,Kevin Knowles,Mark Mirochnick,William Murtaugh,Emmanuel Patras,Mauricio Pinilla,Jean van Wyk,Frances Whalen +44 more
TL;DR: In this article, the safety and efficacy of three antiretroviral regimens started in pregnancy were compared: dolutegravir, emtricitabine, and tenofovir alafenamide fumarate.